Abstract
Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1080/14733400410001669533
Journal: The Women's Oncology Review | Publication Date: Jan 1, 2004 |
Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer
Join us for a 30 min session where you can share your feedback and ask us any queries you have